Home / Member Spotlight
Biosimilars Council works to ensure a positive environment for patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/0jAeG0TOPj
[email protected] shares additional proof points for #biosimilars. Policymakers can keep the momentum going for patients and payers by supporting shared savings and other initiatives that increase access to biosimilars.
Big #biosimilar news: Ronny Gal @AB_insights calculates that #biosimilar savings are now $6.5 billion (annualized) and growing 👇
Spending down -31% for reference molecules
@ScottGottliebMD was right. We shouldn’t give up on biosimilars #notowel
(Sorry, no link to full report)
601 New Jersey Ave NW, Suite 850
Washington DC 20001
Sign up for our Newsletter
©2020 Biosimilars Council
Biosimilars Council is a division of the Association for Accessible Medicines.
Sign up for Biosimilars Council Newsletter to hear about the field, learn about events, and find out how you can make an impact.
Never see this message again.